Stock listing
Akebia Therapeutics, Inc.
Selected listing: A1XF0S · LS · EUR · DE
Akebia Therapeutics, Inc. (Lang & Schwarz: A1XF0S), Health Technology. Latest release Oct 6, 2026: Akebia Therapeutics Announces Late-Breaking VOICE Trial…
- Ticker
- Lang & Schwarz: A1XF0S
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Akebia Therapeutics, Inc.
The company focuses on developing and commercializing innovative therapies for patients with kidney disease. Akebia is committed to addressing unmet medical needs in this area through its research and development efforts.
Latest news from Akebia Therapeutics, Inc.
Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026
October 6, 2026
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2026
Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases
September 14, 2026
Akebia Therapeutics to Conduct Investor Meetings at the 2026 Wells Fargo Healthcare Conference in Boston
September 1, 2026
Akebia Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
August 5, 2026
Events
Research Akebia Therapeutics, Inc.
Akebia Therapeutics, Inc. company profile
View the public company page for Akebia Therapeutics, Inc. on 6ix.
Akebia Therapeutics, Inc. news
Read company news and market updates connected to Akebia Therapeutics, Inc..
Akebia Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Akebia Therapeutics, Inc..
Alternate listings
AKBA:NASDAQ
US · USD
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:TRADEGATE
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
A1XF0S:LSX
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AKBA:BOATS
US · USD
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:GETTEX
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:HAM
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:BX
CH · CHF
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:DUS
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:FWB
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:MUN
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.
AX9:SWB
DE · EUR
Alternate listing for Akebia Therapeutics, Inc.; the primary context on this page is A1XF0S:LS.